Endocrine NM Flashcards

1
Q

Adrenal glands location

A

Retroperitoneum
Below diaphragm
Superior and medially to kidney
Between D12 and L1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Glomerular zone

A

Mineralcorticoid hormones
Aldosterone - - control BP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Fascicular zone

A

75% of cortex
Glucocorticoid
Cortisol - - glycemic control

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Reticular zone

A

Androgens

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Medulla

A

25% adrenal mass
From entoderm, chromaphine cells
Catecholamines
Adrenalin, noradrenalin
Degrade to metanephrines

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Adrenal uptake

A

Analog of cholesterol (precursor of steroid hormones)
50% modulated by ACTH
30% by RAS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

NP-59 protocol

A

I131-iodomethylnorcholesterol
1 mCi
II, IV, VII day image
High energy collimator
20-30 min, 500k-1mln counts
Photopeak 364 keV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

NP-59 preparation

A

Thyroid block 3 days before

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

NP-59 uptake

A

Liver
Gallbladder
Colon (require laxative)
Add Tc-colloid - - taken up by liver - - subtraction - - adrenal visualization

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

NP-59 normal

A

Symmetric uptake of adrenal on II day
Right adrenal closer to liver - - scatter - - more active uptake

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Scintadren

A

Se75-selenomethylnorcholesterol
0.16-0.22 mCi
Middle energy collimator

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Cushing

A

Hypercortisolism - - image of cortex by NP-59
ACTH-dependent - - intense symmetric uptake in enlarged glands
Cortisol hypersecreting adenoma - - monolateral uptake, contralateral not visualized
Cortical nodular hyperplasia - - bilateral asymmetric uptake
Corticoadrenal CA - - lack of adrenal glands

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Primary hyperaldosteronism

A

Conn sy
Corticoadrenal adenoma
Bilateral hyperplasia of glomerular zone
Carcinoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Secondary hyperaldosteronism

A

Renin elevated
Arterial hypertension
Hypokalemia
Muscular disorders

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

ACTH suppression with dexamethasone

A

1-4 mg dexamethasone PO 7 days before and continue
Stop ACE inhibitor, spironolactone, diuretics
Cholesterol uptake in fascicular zone decreased
Good image of glomerular and reticular zone
DD adenoma vs bilateral hyperplasia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Image interpretation
Limitation
Indication

A

Normal - symmetric uptake 4-5 days after
Adrenal visualization before 4th day - - adenoma (unilateral) or hyperplasia (bilateral)
Not identify adenoma in case of hyperplasia
Primary hyperaldosteronism + normal CT

17
Q

Adrenal incidentaloma

A

Benign adenoma - <3 cm, fat, <10 HU
Atypical - hemorrhage, no fat, necrosis, calcification, larger
>4 cm - malignant
>10 HU - - relative washout >40%, abs washout >60% (adenoma)

18
Q

Adrenal MTS

A

Lung
Breast
Renal
Ovaries
GIT
Lymphoma
Melanoma

19
Q

Adrenal medulla pathology

A

Pheo
Paraganglioma

20
Q

MIBG

A

Guanethidine analog
WBS, SPECT 4h and 24h
Optimal for Pheo
Identify extra adrenal Pheo, MTS, post surgery recurrence

21
Q

I131-MIBG

A

Image >24 h
False negative

22
Q

I123-MIBG

A

Higher photon flux
Greater detection
Efficiency
Better spatial resolution
Lower radiation
Easier acquisition

23
Q

Octreoscan = In111-pentetriotide

A

Somatostatin analog
WBS, SPECT 4h and 24h, >24h for uptake on abdomen
Less sensitive for adrenal lesions due to high physiologic kidney uptake
More sensitive for Paraganglioma of head and neck
More accurate in MTS

24
Q

FDG

A

Not in protocol for Pheo

25
Q

FDOPA

A

Analog of dopamine precursor
Same specificity as MIBG
Better spatial resolution
Greater signal-to-noise ratio
Esp Pheo of head and neck

26
Q

Adrenal Ca genetic

A

Beckwith - Wiedeman - - in children
Li-Fraumeni - - mutation in p53 gene
MEN1 25-40%

27
Q

Suspicious adrenal Ca

A

> 4 cm
Irregular margins
Central necrosis/haemorrhage
Enhancement
Invasion
Calcification

28
Q

Adrenal Ca poor prognosis

A

> 50 years
Positive resection margins
N, M
Poorly diff

29
Q

Functioning adrenal Ca

A

<5 cm
Female
Cushing
Female virilization or male feminization
Conn sy

30
Q

Non-functioning adrenal Ca

A

> 10 cm
Male
Abd pain
Fullness
Palpable mass

31
Q

Adrenal Ca image

A

CT - study of choice to dd benign vs malignant
FDG - limited uptake in adenoma, increased uptake in cancer

32
Q

Most appropriate indication for Corticoadrenal scintigraphy

A

Cortisol hypersecreting adenoma

33
Q

Suppression with dexamethasone

A

Stop ACTH stimulation - - reduce uptake in fascicular zone
For hyperaldosteronism and hyperandrogenism

34
Q

Drugs interfere with MIBG

A

Tricyclic antidepressants
Antipsychotics
Beta blockers
Reserpine
Ca-channel blockers
Cocaine
Sympathomimetics

35
Q
A

NP-59 + Tc-colloid subtraction

36
Q
A

NP-59
Right adenoma

37
Q
A

NP-59
Bilateral hyperplasia

38
Q
A

MIBG
Pheo

39
Q
A

Octreoscan
Paraganglioma